Ascend Wellness delivered a flat top-line in Q2 2025, with net revenue of $127.3 million versus prior-year period declines of approximately 10% and a modest sequential decline of about 0.5%. The quarter showcased meaningful profitability progress: adjusted EBITDA of $28.6 million and a 22.4% adjusted EBITDA margin, up 130 basis points sequentially, underpinned by a 260 basis point expansion in adjusted gross margin to 43.4% driven by stronger high-margin CPG product mix and disciplined pricing. GAAP operating income remained slightly negative at -$1.0 million, and net income was -$24.4 million as a result of non-operating items including interest and tax effects. Management highlighted ongoing cost savings, with the company achieving and surpassing its initial $30 million annualized cost-savings target, and a continued emphasis on financial discipline and cash generation (10th consecutive quarter of positive cash flow from operations). The balance sheet remained solid with $95.3 million of cash and equivalents at quarter end and a strategic debt-reduction milestone: jointly retiring the remaining $60 million term loan in May 2025 via $10 million cash and a $50 million private placement, extending runway given a 2029 indenture maturity. The quarter also featured rapid progress on the retailer densification strategy (5 stores added in H1 to 44 total; 15 in the development pipeline, targeting 60 stores including partner locations). Management emphasized a customer-first CPG and digital strategy (225 SKUs launched YTD; 134 SKUs in Q2; rollout of a next-generation e-commerce platform with Ascend Pay and a refreshed loyalty program across the footprint). Looking ahead, the company guides Q3 flat-to-low-single-digit revenue growth with adjusted EBITDA margin guidance of 22%–23%, and expects roughly 300 new SKUs in H2 2025 (with >175 in Q3), supported by ongoing automation and production efficiencies. Key risks include persistent price compression, competitive overbuilding in select markets, regulatory uncertainty, and the pace of store openings (notably New Jersey). Investors should monitor store openings, regulatory developments, commodity and canopy dynamics, and the pace of margin expansion from the ongoing cost-savings initiatives.